MSFHR's announces first Innovation to Commercialization funding recipients

Ten UBC researchers are to receive funding from Michael Smith Foundation for Health Research's inaugural Innovation to Commercialization (I2C) competition.

The Innovation to Commercialization (I2C) Program is designed to help researchers advance discoveries or inventions towards commercialization by supporting commercialization activities that strengthen the value of their intellectual property, facilitate collaboration and attract future investment.

See MSFHR announcement | Full list of i2C award recipients

UBC Funding Recipients

Du, Caigan
Development of a novel organ preservation solution in transplantation
Research Location: Vancouver Prostate Centre / VCHRI

Ghahary, Aziz
Liquid skin substitute accelerates burn and non-healing wounds
​Research Location: ICORD / VCHRI

Granville, David
A novel therapeutic for inflammatory skin diseases
​Research Location: ICORD / VCHRI

Krassioukov, Andrei
Servo-controlled device to maintain physiological functioning
Co-funded with International Collaboration on Repair Discoveries (ICORD)
​Research Location: ICORD / VCHRI

Kwon, Brian
Near infrared spectroscopy for the hemodynamic monitoring of acute spinal cord injury
​Research Location: ICORD / VCHRI

Lester, Richard
Smart Text Analytic Tools (STAT) for analysis of patient-centred communications to strengthen health systems in BC
​Research Location: VCHRI

MacAulay, Calum
Genomic Organization At Large (GOALS) predicts aggressive biological behaviour in prostate and breast cancers
​Research Location: BC Cancer Agency

Minchinton, Andrew
DNA-PK inhibitors for use in combination with radiation therapy
​Research Location: BC Cancer Agency

Ong, Christopher
Development of a novel biotherapeutic fusion protein inhibitor for treatment of advanced prostate cancer
​Research Location: Vancouver Prostate Centre / VCHRI

Roberge, Michel
Preclinical evaluation of gentamicin B1 as treatment for inherited skin fragility disorders caused by nonsense mutations
​Research Location: Life Sciences Institute